[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration].
Nagano
Hiroaki
H
Department of Surgery, Graduate School of Medicine, Osaka University, Japan.
Sakon
Masato
M
Monden
Morito
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015996:Survival Rate
D016898:Interferon-alpha; D005472:Fluorouracil